Doxorubicin-loaded human serum albumin nanoparticles overcome transporter-mediated drug resistance in drug-adapted cancer cells

Scholarly Works

• Grimsley, H. E.; Antczak, M.; McLaughlin, K.-M.; Nist, A.; Mernberger, M.; Stiewe, T.; Speidel, D.; Harper-Wynne, C.; Cox, K.; Cinatl, J.; Wass, M.; Garrett, M. D.; Michaelis, M. Resistance patterns in drug-adapted cancer cell lines reflect complex evolution in clinical tumors. Cold Spring Harbor Laboratory 2024. doi:10.1101/2024.01.20.576412
• Verma, R.; Akter, R.; Kumar, M.; Bhatt, S.; Tiwari, A.; Tiwari, V.; Tagde, P.; Pandey, P.; Mittal, V.; Purohit, D.; Redhu, R.; Rahman, M. H.; Kaushik, D. Exploring the Role of Nanotherapeutics for Diagnosis and Treatment of Solid Tumor. Current Nanoscience 2024, 20, 109–129. doi:10.2174/1573413719666230110124509
• Patel, R.; Kuwar, U.; Dhote, N.; Alexander, A.; Nakhate, K.; Jain, P.; Ajazuddin. Natural Polymers as a Carrier for the Effective Delivery of Antineoplastic Drugs. Current drug delivery 2024, 21, 193–210. doi:10.2174/1567201820666230112170035
• Babunagappan, K. V.; Seetharaman, A.; Ariraman, S.; Santhosh, P. B.; Genova, J.; Ulrih, N. P.; Sudhakar, S. Doxorubicin loaded thermostable nanoarchaeosomes: a next-generation drug carrier for breast cancer therapeutics. Nanoscale Advances 2024. doi:10.1039/d3na00953j
• Lee, J.; Choi, M.-K.; Song, I.-S. Recent Advances in Doxorubicin Formulation to Enhance Pharmacokinetics and Tumor Targeting. Pharmaceuticals (Basel, Switzerland) 2023, 16, 802. doi:10.3390/ph16060802
• Sandha, K. K.; Behera, C.; Chibber, P.; Kumar, R.; Kumar, A.; Mondhe, D. M.; Singh, G.; Gupta, P. N. Antifibrotic Agent Mediated Tumor Microenvironment Modulation and Improved Nanomedicine Delivery in Solid Tumor. Molecular pharmaceutics 2023, 20, 2927–2941. doi:10.1021/acs.molpharmaceut.2c01081
• Kulkarni, S. Natural Polymers-Based Nanoparticles Targeted to Solid Tumors. Environmental Chemistry for a Sustainable World; Springer International Publishing, 2022; pp 75–102. doi:10.1007/978-3-031-14848-4_3
• Paul, M.; Itoo, A. M.; Ghosh, B.; Biswas, S. Current trends in the use of human serum albumin for drug delivery in cancer. Expert opinion on drug delivery 2022, 19, 1449–1470. doi:10.1080/17425247.2022.2134341
• Sharma, P.; Hasan, M. R.; Narang, J. Bio-inspired Protein-Based Nanoparticles in Cancer Therapy. Handbook of Oxidative Stress in Cancer: Therapeutic Aspects; Springer Nature Singapore, 2022; pp 2917–2939. doi:10.1007/978-981-16-5422-0_130
• Sarkar, M.; Wang, Y.; Ekpenyong, O.; Liang, D.; Xie, H. Pharmacokinetic behaviors of soft nanoparticulate formulations of chemotherapeutics. Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology 2022, 15, e1846. doi:10.1002/wnan.1846
• Kulig, K.; Ziąbka, M.; Pilarczyk, K.; Owczarzy, A.; Rogóż, W.; Maciążek-Jurczyk, M. Physicochemical Study of Albumin Nanoparticles with Chlorambucil. Processes 2022, 10, 1170. doi:10.3390/pr10061170
• Sharma, P.; Hasan, M. R.; Narang, J. Bio-inspired Protein-Based Nanoparticles in Cancer Therapy. Handbook of Oxidative Stress in Cancer: Therapeutic Aspects; Springer Singapore, 2022; pp 1–24. doi:10.1007/978-981-16-1247-3_130-1
• Sozer, S. C.; Akdogan, Y. Characterization of Water Solubility and Binding of Spin Labeled Drugs in the Presence of Albumin Nanoparticles and Proteins by Electron Paramagnetic Resonance Spectroscopy. ChemistrySelect 2022, 7. doi:10.1002/slct.202103890
• Yu, L.; Hua, Z.; Luo, X.; Zhao, T.; Liu, Y. Systematic interaction of plasma albumin with the efficacy of chemotherapeutic drugs. Biochimica et biophysica acta. Reviews on cancer 2021, 1877, 188655. doi:10.1016/j.bbcan.2021.188655
• Niculescu, A.-G.; Grumezescu, A. M. Polymer-Based Nanosystems-A Versatile Delivery Approach. Materials (Basel, Switzerland) 2021, 14, 6812. doi:10.3390/ma14226812
• Bojkova, D.; Costa, R.; Bechtel, M.; Ciesek, S.; Michaelis, M.; Cinatl, J. Targeting pentose phosphate pathway for SARS-CoV-2 therapy. Metabolites 2021, 11, 699. doi:10.3390/metabo11100699
• Rothenburger, T.; Thomas, D.; Schreiber, Y.; Wratil, P. R.; Pflantz, T.; Knecht, K. M.; Digianantonio, K.; Temple, J.; Schneider, C.; Baldauf, H.-M.; McLaughlin, K.-M.; Rothweiler, F.; Bilen, B.; Farmand, S.; Bojkova, D.; Costa, R.; Ferreirós, N.; Geisslinger, G.; Oellerich, T.; Xiong, Y.; Keppler, O. T.; Wass, M. N.; Michaelis, M.; Cinatl, J. Differences between intrinsic and acquired nucleoside analogue resistance in acute myeloid leukaemia cells. Journal of experimental & clinical cancer research : CR 2021, 40, 317. doi:10.1186/s13046-021-02093-4
• Kudłacik-Kramarczyk, S.; Głąb, M.; Drabczyk, A.; Kordyka, A.; Godzierz, M.; Wrobel, P. S.; Krzan, M.; Uthayakumar, M.; Kędzierska, M.; Tyliszczak, B. Physicochemical Characteristics of Chitosan-Based Hydrogels Containing Albumin Particles and Aloe vera Juice as Transdermal Systems Functionalized in the Viewpoint of Potential Biomedical Applications. Materials (Basel, Switzerland) 2021, 14, 5832. doi:10.3390/ma14195832
• Kudłacik-Kramarczyk, S.; Drabczyk, A.; Głąb, M.; Gajda, P.; Czopek, A.; Zagórska, A.; Jaromin, A.; Gubernator, J.; Makara, A.; Tyliszczak, B. The Development of the Innovative Synthesis Methodology of Albumin Nanoparticles Supported by Their Physicochemical, Cytotoxic and Hemolytic Evaluation. Materials (Basel, Switzerland) 2021, 14, 4386. doi:10.3390/ma14164386
• Rothenburger, T.; Thomas, D.; Schreiber, Y.; Wratil, P. R.; Pflantz, T.; Knecht, K. M.; Digianantonio, K.; Temple, J.; Schneider, C.; Baldauf, H.-M.; McLaughlin, K.-M.; Rothweiler, F.; Bilen, B.; Farmand, S.; Bojkova, D.; Costa, R.; Ferreirós, N.; Geisslinger, G.; Oellerich, T.; Xiong, Y.; Keppler, O. T.; Wass, M. N.; Michaelis, M.; Cinatl, J. Differences between intrinsic and acquired nucleoside analogue resistance in acute myeloid leukaemia cells. Cold Spring Harbor Laboratory 2021. doi:10.1101/2021.07.19.452885

Explore citations to this article at